Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus
about
Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.CXCR3 in T cell function.C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?Serum level of eight cytokines in Han Chinese patients with systemic lupus erythematosus using multiplex fluorescent microsphere method.Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus.Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis.Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosusBlockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome.CXCR3 ligands: redundant, collaborative and antagonistic functions.MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus.Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options.Pharmacokinetic and pharmacodynamic relationship of AMG 811, an anti-IFN-γ IgG1 monoclonal antibody, in patients with systemic lupus erythematosus.Effects of vitamin D3 on expression of tumor necrosis factor-alpha and chemokines by monocytes.IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis.Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study.Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.The Role of CXC Chemokines in Pulmonary Fibrosis of Systemic Lupus Erythematosus Patients.Autoantibodies, complement and type I interferon as biomarkers for personalized medicine in SLE.Tailoring Immune Responses toward Autoimmunity: Transcriptional Regulators That Drive the Creation and Collusion of Autoreactive Lymphocytes.TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.
P2860
Q34583337-89365AA2-8149-4120-B5F1-41D8FFAAAA6BQ34726782-FB3E67A3-8E55-4236-9EBA-B597587034A2Q34729450-50D52606-B7D4-4509-8026-28B5A30058DCQ35082621-5C72725E-1457-4A57-A2F1-B82A281E1F86Q35631856-E3A16774-1FA5-4D36-9AD9-EE0325972F9EQ35902490-4BCB3274-3062-4E90-A968-5F03FD232393Q36219637-8F5A5572-FCE1-4687-873E-4C15AD58C477Q36289499-7DB6AA74-88EF-44FE-8974-F0D2263BA1CFQ36634362-5CC7412F-C32E-4C61-84A7-68BCDA7EA3F3Q37320550-7B628444-6A3F-4758-9CD9-DCBFA65D6C08Q37587370-FFA4676F-0AB9-4A66-8C56-1CA5E541BE92Q37827339-6D6CBB65-8B3A-4F7D-93D0-6E980BD9B396Q38655827-8FBFB0CC-880B-4B67-9553-20B67E0090B4Q38867891-48AC33A1-A1C1-4917-8CF9-1F37823575ACQ39130536-3A83709C-423A-43E8-98D5-65675391BB5DQ39665707-A52E7164-1AB2-4C08-847D-87FDEF70A381Q44911567-3F5C30F4-20BF-44FB-BA1B-0C750134244BQ46702259-65E90A7A-7F4E-4F95-9CA6-9EEF2E8DACE3Q47267579-9DCDFEAD-53A2-4464-8884-3747BE9A4FEBQ47875729-136D6B2B-9430-47C6-BD18-C95E0454EF05Q51030902-011A9B1C-8404-4D51-9152-18CF4B1BDD8EQ51603884-E2DE4814-484B-4A78-8435-3659A33F1603Q51724948-D043B4C6-ACDC-488B-B4B5-F6018B2B255BQ55030447-08316A70-5C09-46DD-81AA-63A61094339BQ55379196-CB8ED86C-E683-45AC-8957-5CA2CB22E59D
P2860
Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus
description
im April 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 23 January 2009
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2009
@uk
name
Enhanced expression of interfe ...... n systemic lupus erythematosus
@en
Enhanced expression of interfe ...... n systemic lupus erythematosus
@nl
type
label
Enhanced expression of interfe ...... n systemic lupus erythematosus
@en
Enhanced expression of interfe ...... n systemic lupus erythematosus
@nl
prefLabel
Enhanced expression of interfe ...... n systemic lupus erythematosus
@en
Enhanced expression of interfe ...... n systemic lupus erythematosus
@nl
P2093
P2860
P1476
Enhanced expression of interfe ...... n systemic lupus erythematosus
@en
P2093
B Y H Thong
P2860
P304
P356
10.1111/J.1365-2249.2009.03880.X
P407
P577
2009-01-23T00:00:00Z